Brief: Quotient Limited Announces Receipt Of U.S. FDA Emergency Use Authorization For Mosaiq Covid-19 Antibody Test
28/09/2020 12:15
Sept 28 (Reuters) - Quotient Ltd QTNT.O :
* QUOTIENT LIMITED ANNOUNCES RECEIPT OF U.S. FDA EMERGENCY
USE
AUTHORIZATION (EUA) FOR MOSAIQ COVID-19 ANTIBODY TEST
Source text for Eikon: ID:nGNX4vWVXj
Further company coverage: QTNT.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Quotient
See all newsBrief: Quotient Ltd Enters Into Amended And Restated Transaction Support Agreement
U.S. STOCKS ON THE MOVE-Tesla, Exxon Mobil, Chevron
Quotient down on plans to delist from Nasdaq
Brief: Quotient Limited Announces Intent To Voluntary Delist From The Nasdaq Global Market
U.S. STOCKS ON THE MOVE-Organon, Veracyte, InfuSystem